Re: RVNC PF Advancement to a 2b is the absolute wrong goal for shareholders in the long run. A successful outcome of a well designed trial is my preferred goal. As I've said before, I've never liked the PF indication for RVNC's drug (or any drug for that matter). Too difficult to diagnose correctly.